Generex Biotechnology (GNBT) Income Statement

Revenues, net
Cost of Goods Sold
Gross profit
Research and development	71.03K
Research and development - related party
Selling and marketing
General and administrative	73.27K
General and administrative - related party
Total Operating Expenses	144.3K
Operating Loss	-144.3K
Miscellaneous income
Income from assets held for investment, net (Note 13)
Interest income	0
Interest expense	-106.86K
Change in fair value of derivative liabilities (Note 11)	1.17M
Loss on extinguishment of debt
Net (Loss)/Income Before Undernoted
Minority Interest Share of Loss
Net (Loss) /Income	918.36K
Preferred Stock Dividend
Net (Loss)/Income Available to Common Stockholders
Basic (in dollars per share)	0
Diluted (in dollars per share)	0
Basic (in shares)
Diluted (in shares)

Entities mentioned with GNBT

View All Entities